Medco has moved into the mopping up phase with more than 90% of the company’s shares under its control.
Most executives have left the company already with legal and financial staff finalising asset sales and transfers. Santos is buying Novus’ Australian and Indonesian assets while Medco has its foot on the Middle East and United states-based properties.